Intelligent Historical Income Statement

Stocks . USA . 
Stock . Intelligent Bio Solutions
INBS Stock  USD 1.65  0.02  1.20%   
Historical analysis of Intelligent Bio income statement accounts such as Selling General Administrative of 4.9 M or Other Operating Expenses of 8.3 M can show how well Intelligent Bio Solutions performed in making a profits. Evaluating Intelligent Bio income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Intelligent Bio's future profits or losses.
Cash Flow   Balance Sheet     Income Statement
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Intelligent Bio Solutions latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Intelligent Bio Solutions is a good buy for the upcoming year.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intelligent Bio Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

About Intelligent Income Statement Analysis

Intelligent Bio Solutions Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Intelligent Bio shareholders. The income statement also shows Intelligent investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Balance Sheet
Statement
Details
Cash Flow
Statement
Details
Financial
Indicators
Details
Valuation
Indicators
Details

Intelligent Bio Income Statement Chart

At this time, Intelligent Bio's Depreciation And Amortization is comparatively stable compared to the past year. Research Development is likely to gain to about 1.9 M in 2024, whereas Selling General Administrative is likely to drop slightly above 4.9 M in 2024.
Interest Expense  Selling General Administrative  Other Operating Expenses  Research Development  Total Operating Expenses  Interest Income  
Add Fundamental

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Intelligent Bio Solutions. It is also known as Intelligent Bio overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Interest Income

Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.
Most accounts from Intelligent Bio's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Intelligent Bio Solutions current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intelligent Bio Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
At this time, Intelligent Bio's Depreciation And Amortization is comparatively stable compared to the past year. Research Development is likely to gain to about 1.9 M in 2024, whereas Selling General Administrative is likely to drop slightly above 4.9 M in 2024.
 2021 2023 2024 (projected)
Interest Expense7.5K167.1K158.8K
Depreciation And Amortization966.7K1.2M1.4M

Intelligent Bio income statement Correlations

Depreciation And Amortization
Interest Expense
Selling General Administrative
Other Operating Expenses
Operating Income
Ebit
Research Development
Ebitda
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Net Income
Income Tax Expense
Net Interest Income
Interest Income
Net Income From Continuing Ops
Minority Interest
Gross Profit
Depreciation And Amortization
0.470.360.39-0.27-0.430.390.110.43-0.53-0.29-0.40.93-0.170.31-0.17-0.690.88
Interest Expense
0.47-0.42-0.40.520.420.430.77-0.380.3-0.720.430.69-0.91-0.430.480.150.38
Selling General Administrative
0.36-0.420.96-0.79-0.83-0.16-0.70.95-0.820.39-0.840.110.680.8-0.63-0.620.57
Other Operating Expenses
0.39-0.40.96-0.88-0.92-0.09-0.770.99-0.910.46-0.910.10.640.75-0.78-0.550.55
Operating Income
-0.270.52-0.79-0.880.980.260.91-0.880.95-0.720.980.04-0.73-0.680.880.55-0.32
Ebit
-0.430.42-0.83-0.920.980.090.85-0.930.99-0.551.0-0.11-0.66-0.750.870.62-0.48
Research Development
0.390.43-0.16-0.090.260.090.280.00.03-0.680.140.33-0.42-0.190.060.120.2
Ebitda
0.110.77-0.7-0.770.910.850.28-0.770.78-0.760.860.43-0.86-0.630.840.30.01
Total Operating Expenses
0.43-0.380.950.99-0.88-0.930.0-0.77-0.920.43-0.920.120.620.74-0.78-0.570.55
Income Before Tax
-0.530.3-0.82-0.910.950.990.030.78-0.92-0.470.99-0.22-0.57-0.730.840.64-0.56
Total Other Income Expense Net
-0.29-0.720.390.46-0.72-0.55-0.68-0.760.43-0.47-0.57-0.450.710.23-0.59-0.2-0.27
Net Income
-0.40.43-0.84-0.910.981.00.140.86-0.920.99-0.57-0.09-0.68-0.760.850.62-0.46
Income Tax Expense
0.930.690.110.10.04-0.110.330.430.12-0.22-0.45-0.09-0.420.050.18-0.580.78
Net Interest Income
-0.17-0.910.680.64-0.73-0.66-0.42-0.860.62-0.570.71-0.68-0.420.63-0.54-0.49-0.09
Interest Income
0.31-0.430.80.75-0.68-0.75-0.19-0.630.74-0.730.23-0.760.050.63-0.64-0.550.58
Net Income From Continuing Ops
-0.170.48-0.63-0.780.880.870.060.84-0.780.84-0.590.850.18-0.54-0.640.21-0.28
Minority Interest
-0.690.15-0.62-0.550.550.620.120.3-0.570.64-0.20.62-0.58-0.49-0.550.21-0.59
Gross Profit
0.880.380.570.55-0.32-0.480.20.010.55-0.56-0.27-0.460.78-0.090.58-0.28-0.59
Click cells to compare fundamentals

Intelligent Bio Account Relationship Matchups

High Positive Relationship

Net Income
+ 1.0
Ebit
Total Operating Expenses
+ 0.99
Other Operating Expenses
Income Before Tax
+ 0.99
Ebit
Net Income
+ 0.99
Income Before Tax
Ebit
+ 0.98
Operating Income
Net Income
+ 0.98
Operating Income

High Negative Relationship

Total Operating Expenses
- 0.93
Ebit
Net Income
- 0.92
Total Operating Expenses
Income Before Tax
- 0.92
Total Operating Expenses
Ebit
- 0.92
Other Operating Expenses
Net Income
- 0.91
Other Operating Expenses
Income Before Tax
- 0.91
Other Operating Expenses

Intelligent Bio income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization57.9K151.0K5.2M966.7K1.2M1.4M
Interest Expense457.7K1.1M7.5K223.5K167.1K158.8K
Selling General Administrative3.5M2.4M3.7M4.9M9.3M4.9M
Other Operating Expenses2.8M7.0M8.3M9.7M13.4M8.3M
Operating Income(2.7M)(5.6M)(8.3M)(12.6M)(10.3M)(10.8M)
Ebit(2.7M)(7.0M)(8.3M)(10.4M)(10.0M)(10.5M)
Research Development588.2K4.3M3.9M507.4K1.7M1.9M
Ebitda(2.6M)(1.8M)(8.3M)(9.5M)(8.8M)(9.3M)
Total Operating Expenses2.8M7.0M8.3M8.8M11.7M7.9M
Income Before Tax(3.2M)(8.5M)(8.3M)(10.7M)(10.2M)(10.7M)
Total Other Income Expense Net(457.7K)(1.7M)2.9K1.9M92.2K96.9K
Net Income(3.7M)(7.0M)(8.3M)(10.6M)(10.2M)(10.7M)
Income Tax Expense550.3K2.5M(27.9K)190.7K133.0K126.3K
Net Interest Income(457.6K)(1.1M)6.9K(213.9K)(82.3K)(86.4K)
Interest Income97.013.8K14.4K9.7K84.8K89.1K
Net Income From Continuing Ops(3.2M)(7.1M)(8.3M)(10.7M)(10.2M)(10.7M)
Net Income Applicable To Common Shares(3.2M)(7.0M)(8.3M)(10.6M)(9.6M)(10.0M)
Minority Interest29.2K22.9K27.9K32.8K34.2K27.3K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Intelligent Stock Analysis

When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY